Loading
Procedure guide · Reconstructive Plastic Surgery
Keloid SurgeryKeloid surgery removes a scar that has grown beyond the boundary of the original wound and will not settle on its own. Excision alone recurs in a large proportion of cases, frequently worse than before, so surgery is only sensible combined with adjuvant treatment such as steroid injection, pressure, silicone or radiotherapy. For many keloids the first-line treatment is injection rather than an operation.
A keloid is not simply a bad scar. It is a distinct problem in which the scar response fails to switch off, so the scar continues growing beyond the boundaries of the original wound into normal skin and does not regress. That distinguishes it from a hypertrophic scar, which stays within the wound margins and usually softens and flattens over a year. The distinction decides treatment entirely, and getting it wrong is how a modest problem becomes a large one.
The central difficulty follows directly from that definition. Excising a keloid creates a fresh wound in skin that has already demonstrated it forms keloids, so the new wound can produce a keloid in turn, frequently larger than the one removed. Recurrence after excision alone is high enough that surgery on its own is not a reasonable treatment. The rule worth insisting on is simple: keloid surgery is only sensible as part of a plan that includes adjuvant treatment from the moment the excision is done.
For most keloids the right first treatment is not surgery. A course of intralesional steroid injections, given at intervals of several weeks, flattens and softens a keloid and relieves the itching and pain that are frequently the worst part of living with one, all without creating a new wound. It is uncomfortable, it can thin or lighten the skin around the keloid, and it is the recognised first-line approach. Surgery is reserved for keloids too bulky to respond to injection or those that have already failed it.
Where surgery is used, the adjuvant options each have a role. Steroid injected into the wound edges at the time of excision and repeated afterwards is the most widely used. Sustained pressure works well where it can be applied, and earlobe keloids treated with excision and a purpose-made clip worn for months have among the best results in the field. Silicone sheeting is worn daily alongside. A short course of superficial radiotherapy given within a day or two of excision is among the most effective preventive measures and is reserved for large or repeatedly recurrent keloids, because it carries a small theoretical long-term malignancy risk and is generally avoided in young patients and over the thyroid or breast.
Two groups of people are affected disproportionately and should know it before any elective surgery, cosmetic or otherwise. Keloids are considerably more common in people of African, Caribbean and East Asian descent, and in anyone with a family history. Certain sites carry high risk regardless of skin type: the chest, the shoulders, the upper back and the earlobes. Anyone in either group should raise their keloid history at the planning stage of any operation rather than afterwards, because it changes where incisions are placed and what follows them.
Symptoms matter as much as appearance and are frequently the real reason people seek treatment. Keloids itch, sometimes severely, and can be painful or tender. Both usually improve markedly with steroid injection, often faster than the appearance does, and for many patients that symptomatic relief is the outcome that matters most. A treatment plan aimed only at flattening the lump misses half of what the patient came for.
Watching for early recurrence is more useful than it sounds. A keloid that begins to thicken again responds well to injection if it is caught early and poorly once it is established, so reporting any spread beyond the scar line promptly is genuinely worthwhile. Itching returning after a period of quiet is frequently the first sign, before anything is visible.
The practical consequence for anyone considering treatment abroad is that the excision travels easily and the year of injections, pressure and monitoring that determines whether it recurs does not. Surgery without that follow-through is the version with the poor results. Arranging who will provide the adjuvant treatment at home, before booking the operation, matters more to the outcome than the choice of surgeon does.
Keloid surgery is unusual in that excision alone is the wrong treatment. Cutting out a keloid without adjuvant therapy recurs in the majority of cases, frequently producing a larger keloid than the original, because the excision itself is a fresh wound in someone who scars excessively. Every credible protocol therefore pairs surgery with something else: steroid injections beginning at the time of surgery and continuing for months, superficial radiotherapy within 24 to 48 hours, or sustained pressure. A surgeon who offers to remove a keloid with no plan for what follows is offering half a treatment, and that is the single most useful question to ask at consultation.
Keloid surgery decisions depend heavily on site, because the results differ enormously between them. Earlobe keloids do well, with low recurrence when excision is combined with pressure and injections, and they are the reason published series can look encouraging. Keloids on the chest, the shoulders and the upper back do considerably worse, because those areas combine high tension with a strong biological tendency to keloid. For chest and shoulder keloids many specialists favour non-surgical management first, accepting a smaller improvement rather than risking a larger scar.
Keloid surgery is only part of a longer relationship with a tendency that does not go away. Someone who forms keloids will form them again from any subsequent wound, including surgery, piercings, acne and burns. That has practical consequences: elective operations are weighed more carefully, incisions are planned in lower-tension sites where there is a choice, and treatment begins immediately rather than after a scar has thickened. It also means that anyone travelling for keloid treatment needs a clinician at home willing to continue the injection schedule, since the course runs for many months after the operation.
Keloid surgery in darker skin deserves specific mention, because the condition is several times more common in people of African, Caribbean, South Asian and East Asian ancestry, and because treatment carries additional considerations. Steroid injections can lighten the skin around the injection site, an effect that is far more noticeable in darker skin and is frequently permanent. Laser settings also have to be adjusted, since devices that target pigment can burn skin with more of it. These are reasons to seek a surgeon with genuine experience of treating keloids in skin like yours rather than one who treats them occasionally.
Keloid surgery is only one item on a list of treatments, and for many keloids it is not the first. Intralesional steroid injection, repeated every 4 to 6 weeks, remains the most widely used first-line treatment and flattens a substantial proportion of keloids without surgery. Cryotherapy, particularly delivered into the centre of the lesion, works well on smaller keloids. Silicone and pressure help. Laser reduces redness and can soften the scar. Surgery is generally reserved for keloids too large or too long-standing to respond to these.
Keloid surgery combined with superficial radiotherapy has the strongest published record for large or stubborn keloids, with recurrence rates considerably lower than surgery alone. The radiotherapy is given in 1 to 3 small fractions within 48 hours of the excision, at doses far below cancer treatment. It is not available everywhere, since it requires a radiotherapy department willing to schedule urgently. Where it is offered, the theoretical long-term risk of the radiation itself is discussed and is generally considered very small at these doses.
Keloid surgery aftercare determines the result more than the operation does, and it is long. Steroid injections typically continue for 6 to 12 months, pressure is worn daily for a similar period, and silicone is applied throughout. Reviews are scheduled at intervals to catch early thickening, which responds far better than an established recurrence. Anybody arranging keloid treatment should plan the full year rather than the operating day.
Keloid surgery outcomes are best described in terms of control rather than cure. A realistic aim is a flat, soft scar that stays within its original boundary and stops causing itch, pain and tethering. Recurrence remains possible for years and is treated early rather than regarded as a failure. Patients who understand this from the start manage the long follow-up far better than those who expected a single definitive operation.
Surgeons look for these points at the consultation.
Keloid surgery suits people with a keloid causing pain, itching, restricted movement or significant distress, where non-surgical treatment has been tried or the bulk is too great for injection alone, and where adjuvant treatment after excision has been arranged rather than left as an afterthought.
Reasons a good surgeon will ask you to wait or choose something else.
Keloid surgery is avoided where no adjuvant treatment is planned, in active infection, in anyone unable to attend months of follow-up, in sites where recurrence is very likely and symptoms are minimal, and where a course of intralesional steroid has not yet been tried in a keloid small enough to respond to it.
Ask your surgeon which technique they recommend for you and why.
Steroid is injected directly into the keloid at intervals of several weeks, flattening and softening it and relieving itching and pain.
The keloid is cut out and the wound closed, followed immediately by steroid injection, pressure, silicone or radiotherapy to suppress recurrence.
A short course of superficial radiotherapy is given within a day or two of excision, which suppresses the overactive scar response.
Continuous pressure, particularly with earlobe clips after excision, combined with silicone sheeting worn for months.
Step by step, from arrival to discharge.
Keloid surgery begins with the surgeon establishing whether the scar has grown beyond the original wound margins, since a hypertrophic scar is a different problem with a different treatment.
A course of intralesional steroid at intervals of several weeks, which flattens and softens most keloids and relieves itch and pain without creating a new wound.
Where surgery is needed, the adjuvant is decided and arranged first: steroid, pressure, silicone or radiotherapy, with radiotherapy timed for within 24 to 48 hours of excision.
The keloid is removed under local anaesthetic and the wound closed without tension, frequently with steroid injected into the wound edges at the same time.
Radiotherapy within a day or two where planned, pressure devices fitted once the wound has healed, and silicone started as soon as the skin is closed.
Steroid injections at intervals, silicone daily, pressure maintained, and any early thickening treated promptly before it becomes established.
Frequencies follow published guidance; your personal risk depends on your health and the surgeon.
A keloid is not a bad scar. It is a distinct pathology in which the scar response fails to switch off, so the scar grows beyond the boundaries of the original wound into normal skin and does not regress. That difference from a hypertrophic scar, which stays within the wound and usually settles over a year, decides everything about treatment. It also explains the central problem: excising a keloid creates a fresh wound in skin that has already demonstrated it forms keloids.
That is why recurrence dominates this page. Excision alone recurs in a large proportion of cases, and a recurrent keloid is frequently larger than the one removed, so a patient can end up substantially worse off. The rule that follows is simple and worth insisting on: keloid surgery is only sensible as part of a plan that includes adjuvant treatment, whether that is steroid injection, sustained pressure, silicone, or a short course of radiotherapy given within a day or two of the operation. A surgeon proposing excision with no adjuvant plan is proposing something with a poor chance of helping.
For many keloids the right first treatment is not surgery at all. A course of intralesional steroid injections flattens and softens a keloid and relieves the itching and pain that are frequently the worst part of it, without creating a new wound. Injection is the recognised first-line approach, and surgery is reserved for keloids too bulky to respond or those that have failed it.
Two groups of patients are affected disproportionately and should know it. Keloids are considerably more common in people of African, Caribbean and East Asian descent, and in anyone with a family history of them. Certain sites are also high risk regardless of skin type: the chest, the shoulders, the upper back and the earlobes. Anyone in those groups considering any elective surgery, cosmetic or otherwise, should raise their keloid history before it is planned rather than afterwards.
Keloid surgery without adjuvant treatment recurs in a large proportion of cases, and a recurrent keloid is frequently larger than the original. This is the defining risk of the operation.
Steroid injections into dense keloid tissue are painful, and keloids commonly itch throughout treatment.
Because excision creates a new wound in skin already prone to keloid formation, a poorly planned excision can leave a bigger problem than it removed.
Repeated intralesional steroid can thin the skin around the keloid and lighten it, which is more noticeable in darker skin.
The treated area healing darker or lighter than surrounding skin, which is more likely and more persistent in darker skin types.
Wound infection after keloid surgery, which provokes further inflammation and raises the chance of recurrence.
Where post-operative radiotherapy is used, there is a small theoretical long-term malignancy risk, which is why it is reserved for large or repeatedly recurrent keloids.
The operation is the smallest part of keloid surgery. Excising a keloid is usually a short procedure under local anaesthetic with a quick, straightforward wound healing, and patients are frequently surprised how minor it feels. What determines the outcome is everything that happens over the following year.
Adjuvant treatment starts immediately and does not stop for months. Where radiotherapy is used it begins within a day or two of surgery, which is why it has to be arranged in advance rather than considered later. Steroid injections continue at intervals of several weeks. Silicone sheeting is worn daily. Pressure devices, particularly earlobe clips after ear keloid excision, are worn for most of the day for many months. Patients who follow that regimen have markedly lower recurrence than those who do not.
Watching for early recurrence matters more than patients realise. A keloid that begins to thicken again responds well to injection if it is caught early and poorly once it is established, so reporting any spread beyond the scar line promptly is genuinely useful rather than fussing. Itching returning is frequently the first sign.
This is the part that makes travelling abroad for keloid surgery more complicated than it first appears. The excision travels easily; the year of injections, pressure and monitoring does not. Anyone considering it should arrange who will provide the adjuvant treatment at home before booking the operation, because surgery without that follow-through is the version with the poor results.
Days 1-3
Mild discomfort. Where radiotherapy is part of the plan it begins within 24 to 48 hours. Steroid may be injected into the wound edges at the time of surgery.
Days 4-14
Sutures out at 7 to 14 days depending on the site. Pressure devices, such as earlobe clips, start once the wound has healed. Flying is cleared at around day 3.
Weeks 2-12
Silicone sheeting worn daily, pressure maintained, and steroid injections given at intervals of several weeks. This period decides whether the keloid returns.
Months 3-12
Any thickening or spread beyond the scar line is treated promptly, because early recurrence responds to injection far better than established recurrence.
Months 12-24
The scar reaches its final state. Keloids that have not recurred by this point are much less likely to, though late recurrence does happen.
Intralesional steroid flattens and softens most keloids and relieves itch and pain, frequently improving symptoms faster than appearance. For many patients that symptomatic relief is the outcome that mattered most.
Excision with adjuvant treatment substantially reduces recurrence compared with excision alone, and earlobe keloids treated with excision and sustained pressure have among the best results in the field.
Recurrence remains the defining risk. It usually appears within the first year, and a recurrent keloid is frequently larger than the original, which is why surgery without an adjuvant plan is not a reasonable treatment.
Keloids that have not returned by 2 years are much less likely to, though late recurrence does occur. Pigment change in the treated area is common and more persistent in darker skin.
Keloid surgery is inexpensive as an operation and the cost that matters is everything that follows it. Excision is a short day-case procedure under local anaesthetic. The year of steroid injections, pressure devices, silicone and monitoring that determines whether the keloid returns is what should be priced, and it is frequently not mentioned in a surgical quotation at all.
The prices on this site come from verified clinic records for the excision. Where radiotherapy is part of the plan, it is a separate cost and needs a radiotherapy service able to treat within a day or two of the operation, which not every centre can arrange.
For anyone considering this abroad, the practical question is not the price of the excision but who provides the adjuvant treatment at home and what that costs. Surgery without it is the version with poor results, so a cheap excision with no follow-through is not a saving.
Why quotes for the same procedure differ, so you can compare packages fairly.
Options to weigh before deciding, surgical and non-surgical.
The recognised first-line treatment, flattening and softening most keloids and relieving itch and pain without creating a new wound.
Effective for earlobe keloids and well tolerated, with no injections, no radiation and nothing irreversible.
Used in some centres alongside or instead of steroid, particularly for keloids that have not responded to injection alone.
Vascular laser reduces redness and may help itch, and fractional laser can improve texture, though neither flattens a bulky keloid on its own.
Reasonable where the keloid causes no symptoms and is in a site with a high recurrence risk, since surgery could leave a larger problem.
Ask the same questions at every consultation so you can compare answers.
A hypertrophic scar is raised but stays within the boundaries of the original wound, and it usually softens and flattens over a year or so. A keloid grows beyond the original wound into normal skin and does not regress on its own.
The distinction decides treatment. Hypertrophic scars often need nothing more than silicone and time. Keloids need active treatment and carry a high risk of returning after surgery.
Because excision creates a fresh wound in skin that has already shown it forms keloids. The underlying tendency is not removed with the lump, so the new wound can produce a keloid in turn, sometimes larger than the original.
This is why surgery alone is not recommended. Adjuvant treatment after excision, whether steroid, pressure, silicone or radiotherapy, substantially reduces recurrence, and without it the operation has a poor chance of helping.
For most keloids yes. Intralesional steroid is the recognised first-line treatment and it flattens the keloid, softens it and relieves the itching and pain that are often the worst part, all without creating a new wound.
Surgery is reserved for keloids too bulky to respond to injection or those that have already failed it. A surgeon who offers excision without having tried or discussed injection first is skipping a step.
A short course of superficial radiotherapy given within a day or two of excision is among the most effective ways of preventing recurrence, and it is well established for large or repeatedly recurrent keloids.
There is a small theoretical long-term risk of malignancy, which is why it is used selectively rather than routinely, and why it is generally avoided in young patients and over sensitive areas such as the thyroid or breast.
The tendency is largely genetic. Keloids are considerably more common in people of African, Caribbean and East Asian descent and in those with a family history, and certain sites scar badly in almost everyone.
The chest, shoulders, upper back and earlobes are the classic high-risk sites. If you form keloids, raise it before any elective surgery, cosmetic or otherwise, so it can be planned for rather than discovered.
Yes, and they are among the most successfully treated. Excision followed by pressure with a purpose-made earlobe clip worn for months, often with steroid injection, gives good results in most patients.
Repiercing the ear afterwards risks starting the process again. Where it is wanted, it is usually delayed for a year or more and discussed with the surgeon first.
Essentially never. A keloid is benign overgrown scar tissue, not a tumour, and malignant change is exceptionally rare.
What does matter is that a lump assumed to be a keloid should have been diagnosed as one. Any scar lump that ulcerates, bleeds repeatedly or changes rapidly deserves assessment rather than assumption.
Itching and discomfort are among the commonest symptoms of a keloid and frequently the main reason people seek treatment. Both usually improve markedly with steroid injection, sometimes faster than the appearance does.
Some itching continues through the treatment period. Persistent pain or itching returning after a period of quiet is worth reporting, because it can be the first sign of recurrence.
Keloid surgery itself is short, but the adjuvant treatment runs for months: steroid injections at intervals of several weeks, silicone daily, pressure for most of the day where it can be applied, and monitoring for a year or more.
Recurrence usually appears in the first year, so that is the period requiring attention. Keloids that have not returned by 2 years are much less likely to, although late recurrence does occur.
The excision travels easily. The year of injections, pressure and monitoring that determines whether it recurs does not, and surgery without that follow-through is the version with poor results.
Anyone considering it should arrange who will provide the adjuvant treatment at home before booking the operation. That single arrangement matters more to the outcome than the choice of surgeon.
Vascular laser can reduce redness and may help with itching, and fractional laser is sometimes used to improve texture or to help drive steroid into the tissue.
It is an adjunct rather than a treatment on its own. No laser reliably flattens a bulky keloid, and any clinic presenting laser as a standalone cure is overstating it.
One who talks about the adjuvant plan before the operation. A surgeon who describes what happens in the year after excision, and has arranged it, understands the problem. One who describes only the excision does not.
Ask their recurrence rate, what adjuvant treatment they use and why, and who will deliver it if you live elsewhere. Then ask to see their own results at 12 months or later rather than at 6 weeks.
An overactive wound healing response in which the signals that normally switch off collagen production fail to do so, allowing scar tissue to keep growing into surrounding normal skin.
The tendency is largely genetic and is strongly associated with ancestry and family history. Tension at the wound, infection and delayed healing all increase the likelihood in someone already predisposed.
Piercings can be done after keloid surgery, but the risk is real, particularly for cartilage piercings of the upper ear which are a classic site for large keloids. Earlobe piercings carry a lower but genuine risk.
Anyone who has already formed a keloid from a piercing should think carefully before repeating it, including on the other side. Where it is wanted after treatment, most surgeons advise waiting a year or more and discussing it first.
No, and the distinction matters because the treatment differs. Most raised scars are hypertrophic: they stay within the original wound boundary and soften over a year or so, frequently needing nothing more than silicone and time.
A keloid extends beyond the original wound into normal skin and does not regress. If the scar is spreading sideways into untouched skin, that is the feature that identifies it.
A purpose-made pressure device that clips over the earlobe after a keloid has been excised, applying continuous pressure to suppress the scar response.
It is worn for most of the day for many months, frequently six to twelve. Compliance largely determines whether the keloid returns, and earlobe keloids treated this way have among the best results in the field.
NHS2024Regulator
NHS2024Regulator
American Society of Plastic Surgeons2024Professional society
Consultation request
Tell us the procedure and destination you are considering. We forward your request to the verified clinic you select.